Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Anandamide
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ahn K et al. | Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. | 2008 | Chem. Rev. | pmid:18429637 |
Gurney AM et al. | Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. | 2003 | Circ. Res. | pmid:14551239 |
Fernandez-Patron C et al. | Vascular matrix metalloproteinase-2-dependent cleavage of calcitonin gene-related peptide promotes vasoconstriction. | 2000 | Circ. Res. | pmid:11029402 |
Bátkai S et al. | Endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. | 2004 | Circulation | pmid:15451779 |
Hong Z et al. | Role of store-operated calcium channels and calcium sensitization in normoxic contraction of the ductus arteriosus. | 2006 | Circulation | pmid:16982938 |
Alenmyr L et al. | TRPV1 and TRPA1 stimulation induces MUC5B secretion in the human nasal airway in vivo. | 2011 | Clin Physiol Funct Imaging | pmid:21981454 |
Cui N et al. | Restored Plasma Anandamide and Endometrial Expression of Fatty Acid Amide Hydrolase in Women With Polycystic Ovary Syndrome by the Combination Use of Diane-35 and Metformin. | 2017 | Clin Ther | pmid:28291580 |
Schroeder C et al. | Circulating endocannabinoid concentrations during orthostatic stress. | 2009 | Clin. Auton. Res. | pmid:19756829 |
Vogeser M et al. | Release of anandamide from blood cells. | 2006 | Clin. Chem. Lab. Med. | pmid:16599845 |
Busch L et al. | Effects of castration on cannabinoid cb receptor expression and on the biological actions of cannabinoid in the parotid gland. | 2006 | Clin. Exp. Pharmacol. Physiol. | pmid:16487271 |
Ruginsk SG et al. | Anandamide modulates the neuroendocrine responses induced by extracellular volume expansion. | 2013 | Clin. Exp. Pharmacol. Physiol. | pmid:23875874 |
Barun S et al. | Effects of cannabinoid receptor activation on rabbit bisected vas deferens strips. | 2005 | Clin. Exp. Pharmacol. Physiol. | pmid:16173925 |
Mitchell VA et al. | Actions of the endocannabinoid transport inhibitor AM404 in neuropathic and inflammatory pain models. | 2007 | Clin. Exp. Pharmacol. Physiol. | pmid:17880375 |
Tuboly G et al. | Antinociceptive interactions between anandamide and endomorphin-1 at the spinal level. | 2009 | Clin. Exp. Pharmacol. Physiol. | pmid:19018802 |
Dollery C | Investigative clinical pharmacology. | 2011 | Clin. Pharmacol. Ther. | pmid:21862965 |
Zoerner AA et al. | Allergen challenge increases anandamide in bronchoalveolar fluid of patients with allergic asthma. | 2011 | Clin. Pharmacol. Ther. | pmid:21716266 |
Guindon J and Hohmann AG | The endocannabinoid system and pain. | 2009 | CNS Neurol Disord Drug Targets | pmid:19839937 |
Lambert RC et al. | Modulation of neuronal T-type calcium channels. | 2006 | CNS Neurol Disord Drug Targets | pmid:17168746 |
Khanna IK and Alexander CW | Fatty acid amide hydrolase inhibitors--progress and potential. | 2011 | CNS Neurol Disord Drug Targets | pmid:21631410 |
GarcÃa-GarcÃa F et al. | Sleep-inducing factors. | 2009 | CNS Neurol Disord Drug Targets | pmid:19689305 |
Nilsson O et al. | Cannabinoid CB1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures. | 2003 | Comp. Biochem. Physiol. C Toxicol. Pharmacol. | pmid:14659458 |
Després JP | The endocannabinoid system: a new target for the regulation of energy balance and metabolism. | 2007 | Crit Pathw Cardiol | pmid:17667864 |
Kadoi Y et al. | Cannabinoid antagonist AM 281 reduces mortality rate and neurologic dysfunction after cecal ligation and puncture in rats. | 2005 | Crit. Care Med. | pmid:16276190 |
Panagis G et al. | Behavioral pharmacology of cannabinoids with a focus on preclinical models for studying reinforcing and dependence-producing properties. | 2008 | Curr Drug Abuse Rev | pmid:19630731 |
Ligresti A et al. | Endocannabinoid metabolic pathways and enzymes. | 2005 | Curr Drug Targets CNS Neurol Disord | pmid:16375679 |
Maccarrone M et al. | Endocannabinoid degradation, endotoxic shock and inflammation. | 2002 | Curr Drug Targets Inflamm Allergy | pmid:14561206 |
Guindon J and Beaulieu P | The role of the endogenous cannabinoid system in peripheral analgesia. | 2009 | Curr Mol Pharmacol | pmid:20021453 |
Battista N et al. | Endocannabinoids and their involvement in the neurovascular system. | 2004 | Curr Neurovasc Res | pmid:16185189 |
Cravatt BF and Lichtman AH | Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. | 2003 | Curr Opin Chem Biol | pmid:12941421 |
Rice AS | Cannabinoids and pain. | 2001 | Curr Opin Investig Drugs | pmid:11575713 |
Izzo AA et al. | The gastrointestinal pharmacology of cannabinoids. | 2001 | Curr Opin Pharmacol | pmid:11757815 |
Pate DW et al. | Ophthalmic arachidonylethanolamide decreases intraocular pressure in normotensive rabbits. | 1995 | Curr. Eye Res. | pmid:8529418 |
Di Marzo V et al. | Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. | 1999 | Curr. Med. Chem. | pmid:10469888 |
Reggio PH | Endocannabinoid binding to the cannabinoid receptors: what is known and what remains unknown. | 2010 | Curr. Med. Chem. | pmid:20166921 |
Di Marzo V and De Petrocellis L | Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop new endocannabinoid-based therapeutic drugs. | 2010 | Curr. Med. Chem. | pmid:20166923 |
Ashton JC et al. | Cannabinoid CB1 and CB2 receptor ligand specificity and the development of CB2-selective agonists. | 2008 | Curr. Med. Chem. | pmid:18537620 |
Dainese E et al. | Modulation of the endocannabinoid system by lipid rafts. | 2007 | Curr. Med. Chem. | pmid:17979719 |
Kreitzer AC and Regehr WG | Retrograde signaling by endocannabinoids. | 2002 | Curr. Opin. Neurobiol. | pmid:12049940 |
Ohno-Shosaku T and Kano M | Endocannabinoid-mediated retrograde modulation of synaptic transmission. | 2014 | Curr. Opin. Neurobiol. | pmid:24747340 |
Di Marzo V et al. | Endovanilloid signaling in pain. | 2002 | Curr. Opin. Neurobiol. | pmid:12139983 |
Bisogno T et al. | Fatty acid amide hydrolase, an enzyme with many bioactive substrates. Possible therapeutic implications. | 2002 | Curr. Pharm. Des. | pmid:11945157 |
Leweke FM | Anandamide dysfunction in prodromal and established psychosis. | 2012 | Curr. Pharm. Des. | pmid:22716147 |
Di Marzo T et al. | Endocannabinoids: new targets for drug development. | 2000 | Curr. Pharm. Des. | pmid:10903398 |
Palmer SL et al. | Natural and synthetic endocannabinoids and their structure-activity relationships. | 2000 | Curr. Pharm. Des. | pmid:10903399 |
Fowler CJ | "The tools of the trade"--an overview of the pharmacology of the endocannabinoid system. | 2008 | Curr. Pharm. Des. | pmid:18781976 |
Harvey BS et al. | Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability. | 2013 | Cytokine | pmid:23706402 |
Harvey BS et al. | Interleukin 17A evoked mucosal damage is attenuated by cannabidiol and anandamide in a human colonic explant model. | 2014 | Cytokine | pmid:24238999 |
Levin M and Mercola M | Gap junctions are involved in the early generation of left-right asymmetry. | 1998 | Dev. Biol. | pmid:9806775 |
Levin M and Mercola M | Expression of connexin 30 in Xenopus embryos and its involvement in hatching gland function. | 2000 | Dev. Dyn. | pmid:10974676 |
Buznikov GA et al. | A putative 'pre-nervous' endocannabinoid system in early echinoderm development. | 2010 | Dev. Neurosci. | pmid:19907129 |